Sickle Cell Disease

expert roundtables

by Stella T. Chou, MD; Michael Rutledge DeBaun, MD, MPH; and Julie Kanter, MD

Some of the complications of sickle cell disease (SCD) that may be more likely to go unrecognized or underdiagnosed include depression, post-transf......READ MORE

expert roundtables

by Stella T. Chou, MD; Michael Rutledge DeBaun, MD, MPH; and Julie Kanter, MD

Hydroxyurea reduces the frequency of vaso-occlusive crisis (VOC), but some patients with sickle cell disease (SCD) still experience recurrent crise......READ MORE

patient care perspectives

by Michael Rutledge DeBaun, MD, MPH

The successful transition from pediatric to adult care involves overcoming a variety of challenges and barriers, some of which may be structural. M......READ MORE

patient care perspectives

by Stella T. Chou, MD

In patients with sickle cell disease (SCD), hydroxyurea has been shown to reduce morbidity and mortality. Still, adherence to therapy may be a chal......READ MORE

clinical topic updates

by Julie Kanter, MD

While transfusions and disease-modifying treatments improve the morbidity and mortality associated with sickle cell disease (SCD), treatment-relate......READ MORE